The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery

BACKGROUND: High soluble suppression of tumorigenicity-2 (sST2) is a marker of poor prognosis in chronic inflammatory conditions. ST2 and its ligand interleukin (IL)-33 are elevated in adipose tissue of obese individuals. We aimed to evaluate circulating sST2 and IL-33 as possible markers of metabol...

Descripción completa

Detalles Bibliográficos
Autores principales: Demyanets, Svitlana, Kaun, Christoph, Kaider, Alexandra, Speidl, Walter, Prager, Manfred, Oravec, Stanislav, Hohensinner, Philipp, Wojta, Johann, Rega-Kaun, Gersina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045735/
https://www.ncbi.nlm.nih.gov/pubmed/32101157
http://dx.doi.org/10.1186/s12933-020-01001-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045735/
https://www.ncbi.nlm.nih.gov/pubmed/32101157
http://dx.doi.org/10.1186/s12933-020-01001-y

Ejemplares similares